India’s Aurobindo gets USFDA’s OK for its pulmonary tablets ‘Sildenafil’
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil…
Pharmaceuticals, Biotechnology and Life Sciences
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil…
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
India-headquartered pharmaceutical company, Strides Arcolab Limited has change its name to Strides Shasun Limited.
IOLCP has completed its De-bottlenecking/ Re-engineering project for its Ibuprofen Manufacturing facilities at Barnala with project cost of Rs 24 Crores, and has started the enhanced production from Thursday.
One worker died in a fire that broke out at India’s Shashun Pharmaceutical’s new production block during trial & commissioning in Cuddalore API facility on November 16, 2015.
LEO Pharma and Japanese pharmaceutical company Astellas Pharma Inc. have entered into an Asset Purchase Agreement under which Astellas will transfer its global dermatology business to LEO Pharma for € 675 million.
Vishnu Chemicals has reappointed of Ch. Krishna Murthy, Chairman & Managing Director for a period of 5 years
Sanofi and Hanmi Pharmaceutical Co., Ltd. announced Thursday a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments.
Plandaí Biotechnology, Inc., has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients.
Eli Lilly and Company and Innovent Biologics, Inc. has announced an expansion of their drug development collaboration, already one of the largest in China between a multi-national and domestic biopharmaceutical company.